Lakefront Biotherapeutics NV (GXEA.F) Q4 2024 Earnings

30OctConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.97
-0.52
0.94
2.39

Details

Expected EPS
-0.15923173022424003
Actual EPS
-0.758734580592
Surprise EPS
-0.6
Surprise Percent
+376.5%

Description

Lakefront Biotherapeutics NV (GXEA.F) has reported earnings of -0.758734580592 per share for Q4 2024.

0 Comments

Share your thoughts